1-(7-chloro-6-nitro-3,4-dihydroisoquinolin-2(1H)-yl)-2,2,2-trifluoroethanone
|
- $90 - $330
- Product name: 1-(7-chloro-6-nitro-3,4-dihydroisoquinolin-2(1H)-yl)-2,2,2-trifluoroethanone
- CAS: 1097920-65-4
- MF: C11H8ClF3N2O3
- MW: 308.64
- EINECS:
- MDL Number:MFCD20921906
- Synonyms:1-(7-chloro-6-nitro-3,4-dihydroisoquinolin-2(1H)-yl)-2,2,2-trifluoroethanone;1-(7-Chloro-6-nitro-3,4-dihydroisoquinolin-2(1H)-yl)-2,2,2-trifluoroethan-1-one;Ethanone, 1-(7-chloro-3,4-dihydro-6-nitro-2(1H)-isoquinolinyl)-2,2,2-trifluoro-
3 prices
Selected condition：
Brand
- Chemenu
- Crysdot
- TRC
Package
- 50mg
- 1g
- ManufacturerChemenu
- Product numberCM223295
- Product description1-(7-Chloro-6-nitro-3,4-dihydroisoquinolin-2(1h)-yl)-2,2,2-trifluoroethanone 95%
- Packaging1g
- Price$311
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11352847
- Product description1-(7-Chloro-6-nitro-3,4-dihydroisoquinolin-2(1h)-yl)-2,2,2-trifluoroethanone 95+%
- Packaging1g
- Price$330
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberC350235
- Product description1-(7-Chloro-6-nitro-3,4-dihydroisoquinolin-2(1h)-yl)-2,2,2-trifluoroethanone
- Packaging50mg
- Price$90
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Chemenu | CM223295 | 1-(7-Chloro-6-nitro-3,4-dihydroisoquinolin-2(1h)-yl)-2,2,2-trifluoroethanone 95% | 1g | $311 | 2021-12-16 | Buy |
| Crysdot | CD11352847 | 1-(7-Chloro-6-nitro-3,4-dihydroisoquinolin-2(1h)-yl)-2,2,2-trifluoroethanone 95+% | 1g | $330 | 2021-12-16 | Buy |
| TRC | C350235 | 1-(7-Chloro-6-nitro-3,4-dihydroisoquinolin-2(1h)-yl)-2,2,2-trifluoroethanone | 50mg | $90 | 2021-12-16 | Buy |
Properties
Boiling point :453.7±45.0 °C(Predicted)
Density :1.552±0.06 g/cm3(Predicted)
pka :-2.13±0.20(Predicted)
Density :1.552±0.06 g/cm3(Predicted)
pka :-2.13±0.20(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|